Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emil C Reisinger

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Frontiers in Bioengineering and Biotechnology|May 13, 2024
Utilization of a highly adaptable murine air pouch model for minimally invasive testing of the inflammatory potential of biomaterialsFranziska Woitschach, Marlen Kloss, Sabine Kischkel, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 29, 2026
Post-COVID: a specific neuropsychological profile in performance deficitsBritta Müller, Ulrike Balz, Katharina Bartels, et al.
Tropical Medicine & International Health : TM & IH|September 15, 2009
Imbalance of pro- and antifibrogenic genes and bile duct injury in murine Schistosoma mansoni infection-induced liver fibrosisMicha Loebermann, Martina Sombetzki, Cord Langner, et al.
Travel Medicine and Infectious Disease|May 26, 2015
Evaluation of rabies immunogenicity and tolerability following a purified chick embryo cell rabies vaccine administered concomitantly with a Japanese encephalitis vaccineTomas Jelinek, Jakob P Cramer, Sebastian Dieckmann, et al.
Frontiers in Bioengineering and Biotechnology|December 5, 2022
Novel dalbavancin-PLLA implant coating prevents hematogenous <i>Staphylococcus aureus</i> infection in a minimally invasive mouse tail vein modelMarlen Kloss, Caroline Moerke, Franziska Woitschach, et al.
Plos One|September 13, 2022
SARS-CoV-2 surveillance by RT-qPCR-based pool testing of saliva swabs (lollipop method) at primary and special schools-A pilot study on feasibility and acceptabilityAnika Kästner, Petra Lücker, Martina Sombetzki, et al.
Vaccine|May 5, 2024
Safety and immunogenicity of Ad26.COV2.S in adults: A randomised, double-blind, placebo-controlled Phase 2a dose-finding studyVicky Cárdenas, Mathieu Le Gars, Carla Truyers, et al.
Journal of Travel Medicine|March 21, 2016
One-year immunogenicity kinetics and safety of a purified chick embryo cell rabies vaccine and an inactivated Vero cell-derived Japanese encephalitis vaccine administered concomitantly according to a new, 1-week, accelerated primary seriesJakob P Cramer, Tomas Jelinek, Maria Paulke-Korinek, et al.
Vaccines|October 26, 2024
Safety and Humoral Immunogenicity of Different Dose Levels of Ad26.COV2.S as a 2-Dose Regimen in COVID-19 Vaccine-Naïve Healthy Adults: A Phase 3 Randomized Clinical TrialVeronica V Rezelj, Fred Paddenburg, Marie Enajite Diegbe, et al.
Implementation Science : IS|October 8, 2014
Optimizing polypharmacy among elderly hospital patients with chronic diseases--study protocol of the cluster randomized controlled POLITE-RCT trialChristin Löffler, Eva Drewelow, Susanne D Paschka, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Frontiers in Bioengineering and Biotechnology|May 13, 2024
Utilization of a highly adaptable murine air pouch model for minimally invasive testing of the inflammatory potential of biomaterialsFranziska Woitschach, Marlen Kloss, Sabine Kischkel, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 29, 2026
Post-COVID: a specific neuropsychological profile in performance deficitsBritta Müller, Ulrike Balz, Katharina Bartels, et al.
Tropical Medicine & International Health : TM & IH|September 15, 2009
Imbalance of pro- and antifibrogenic genes and bile duct injury in murine Schistosoma mansoni infection-induced liver fibrosisMicha Loebermann, Martina Sombetzki, Cord Langner, et al.
Travel Medicine and Infectious Disease|May 26, 2015
Evaluation of rabies immunogenicity and tolerability following a purified chick embryo cell rabies vaccine administered concomitantly with a Japanese encephalitis vaccineTomas Jelinek, Jakob P Cramer, Sebastian Dieckmann, et al.
Frontiers in Bioengineering and Biotechnology|December 5, 2022
Novel dalbavancin-PLLA implant coating prevents hematogenous <i>Staphylococcus aureus</i> infection in a minimally invasive mouse tail vein modelMarlen Kloss, Caroline Moerke, Franziska Woitschach, et al.
Plos One|September 13, 2022
SARS-CoV-2 surveillance by RT-qPCR-based pool testing of saliva swabs (lollipop method) at primary and special schools-A pilot study on feasibility and acceptabilityAnika Kästner, Petra Lücker, Martina Sombetzki, et al.
Vaccine|May 5, 2024
Safety and immunogenicity of Ad26.COV2.S in adults: A randomised, double-blind, placebo-controlled Phase 2a dose-finding studyVicky Cárdenas, Mathieu Le Gars, Carla Truyers, et al.
Journal of Travel Medicine|March 21, 2016
One-year immunogenicity kinetics and safety of a purified chick embryo cell rabies vaccine and an inactivated Vero cell-derived Japanese encephalitis vaccine administered concomitantly according to a new, 1-week, accelerated primary seriesJakob P Cramer, Tomas Jelinek, Maria Paulke-Korinek, et al.
Vaccines|October 26, 2024
Safety and Humoral Immunogenicity of Different Dose Levels of Ad26.COV2.S as a 2-Dose Regimen in COVID-19 Vaccine-Naïve Healthy Adults: A Phase 3 Randomized Clinical TrialVeronica V Rezelj, Fred Paddenburg, Marie Enajite Diegbe, et al.
Implementation Science : IS|October 8, 2014
Optimizing polypharmacy among elderly hospital patients with chronic diseases--study protocol of the cluster randomized controlled POLITE-RCT trialChristin Löffler, Eva Drewelow, Susanne D Paschka, et al.
Pageof 11